Crohn’s disease (CD) is principally characterized by chronic and
recurrent inflammation of the gastrointestinal tract, most commonly found in the
ileo-colonic region. The chronicity and severity of intestinal inflammation
together contribute to progressive, cumulative, deep, transmural intestinal
damage, including stricturing, obstruction, abscesses, and fistulae. Both
intestinal inflammation and its chronic complications result in a range of
symptoms subsequently leading to patient presentations with diarrhea, abdominal
pain, and anemia related to intestinal blood loss. Measuring disease activity
and severity are essential for decision of treatment intensity early in the
disease course and longitudinal monitoring of therapeutic efficacy. This review
will summarize the transition from subjective symptoms driving disease activity
indices, into increasingly objective and quantitative measures of intestinal
injury by direct mucosal assessment (endoscopy), cross-sectional imaging, and
surrogate biomarkers. Specific commentary on intestinal stricture and perianal
fistula assessment and management are presented in accompanying sections of this
series.